Drug intelligence / Profile preview

bupivacaine + epinephrine + clonidine (Wake Forest University Health Sciences)

Development stage
Phase 4
Lead developer
Wake Forest University Health Sciences
Modality
Small Molecules
Administration
Perineural
01

Overview

The Pectoralis Nerve block (PECS block) is a regional anesthesia technique being evaluated by Wake Forest University Health Sciences for the management of postoperative pain following mastectomy and immediate breast reconstruction. In this specific clinical application, the block involves the ultrasound-guided injection of a local anesthetic solution—typically a combination of bupivacaine, epinephrine, and clonidine—into the fascial planes between the pectoralis major, pectoralis minor, and serratus anterior muscles. Bupivacaine acts as a sodium channel blocker to provide analgesia, epinephrine serves as a vasoconstrictor to prolong the block's duration and reduce systemic absorption, and clonidine acts as an alpha-2 adrenergic agonist to enhance the analgesic effect. The procedure aims to block the medial and lateral pectoral nerves, as well as the long thoracic and thoracodorsal nerves, to reduce opioid consumption and speed recovery.

Other names
Pectoralis Nerve blockPECS blockPECS I and II block
02

Targets

ADRA2A (α2A)ADRB1 (β1)ADRA1A (α1A)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on bupivacaine + epinephrine + clonidine (Wake Forest University Health Sciences).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine + epinephrine + clonidine (Wake Forest University Health Sciences).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call